Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

The end for AbbVie’s bestseller? US FDA approves Amgen’s Humira biosimilar

Amid ongoing patent litigation, the FDA has approved Amgen’s Amjevita: the first US biosimilar version of AbbVie’s top selling rheumatoid arthritis biologic Humira.

First US version of AbbVie's Humira approved

Gates Foundation grant aims to reduce cost of manufacturing rotavirus vaccine

Fixed-bed, high cell density bioreactors and a naturally occurring attenuated viral strain will be used by Batavia Biosciences in an attempt to produce an affordable rotavirus vaccine.

Regeneron thanks Abec for helping it avoid "gremlins" during bio plant set-up

Abec has completed work on Regeneron’s biologics facility in Ireland just 28 months after it was hired to kit out the repurposed computer plant.

Bluebird gene therapy granted EMA accelerated assessment status

Bluebird Bio’s sickle cell disease gene therapy LentiGlobin has been accepted into the EMA’s priority review programme, PRIME.

Pharma 2020 has activated Russian biomanufacturing tech market says GE Healthcare

Government efforts to encourage local drug production have “activated” the Russian biomanufacturing technology market according to GE Healthcare.

Perfusion infusion: WuXi Biologics opens disposable plant as part of $150m expansion

WuXi has responded to global demand for perfusion technologies by opening a commercial scale manufacturing site in China with two 1,000L disposable bioreactors.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...